FAB.L Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jul 2024 @ 10:29):
Our systems believe the stock currently is undervalued by 0.00% compare to its pairs and should correct upwards.

Stats
Dagens volum	25 193
Gjennomsnittsvolum	946 307
Markedsverdi	2.96M
EPS	£-0.0292 ( Q2 \| 2023-09-30 )
Neste inntjeningsdato	( £0 ) 2024-09-27
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-0.340 (Sector) 0 (Industry) 0
ATR14	£0.0830 (2.68%)

AMYT.L -11.73%

APH.L 0.39%

AVCT.L 0.28%

AZN.L -0.39%

BMK.L 7.59%

BVXP.L -2.16%

C4XD.L 27.32%

CIR.L 0.00%

CLIN.L 0.11%

DEST.L -2.51%

DPH.L 0.05%

EAH.L 3.49%

ERGO.L 0.15%

ETX.L -6.74%

EVG.L 2.25%

FAB.L -1.59%

FARN.L -5.08%

FUM.L 2.78%

GDR.L 3.03%

GNS.L 1.45%

GSK.L -0.52%

HCM.L -0.36%

HEMO.L -2.75%

HIK.L -0.58%

IMM.L -1.15%

INDV.L 0.32%

IXI.L -5.25%

MTPH.L 1 794.74%

MXCT.L -2.17%

N4P.L -4.71%

NCYT.L -2.48%

NFX.L -4.71%

OBD.L 0.92%

OKYO.L -24.32%

ONC.L 0.45%

OPTI.L -3.75%

OVB.L -2.22%

OXB.L 2.58%

PRM.L -4.82%

PRTC.L 1.42%

PYC.L -6.25%

REDX.L 31.58%

RENE.L -2.17%

SAR.L 7.00%

SCLP.L -1.86%

SLN.L -0.93%

SNG.L 3.48%

STX.L 2.70%

TILS.L 8.33%

TRX.L -1.15%

VAL.L 0.00%

VEC.L 0.00%

Korrelasjon (AI algo v.1.1b): Undervalued: 0.00% £3.10 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Fusion Antibodies PLC Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Fusion Antibodies PLC Økonomi

Annual	2022
Omsetning:	£2.90M
Bruttogevinst:	£202 000 (6.96 %)
EPS:	£-0.0998

FY	2022
Omsetning:	£2.90M
Bruttogevinst:	£202 000 (6.96 %)
EPS:	£-0.0998

FY	2022
Omsetning:	£4.80M
Bruttogevinst:	£2.47M (51.39 %)
EPS:	£-0.0463

FY	2021
Omsetning:	£4.17M
Bruttogevinst:	£2.02M (48.60 %)
EPS:	£-0.131

Financial Reports:

No articles found.

Fusion Antibodies PLC Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Fusion Antibodies PLC

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.